Endo International
==Overview==
Endo International is a global specialty pharmaceutical company that develops, manufactures, and distributes a broad range of branded and generic pharmaceutical products. The company is headquartered in Dublin, Ireland, and has operations in various countries around the world.
History[edit | edit source]
Endo International was founded in 1997 as a result of a management buyout from DuPont Merck. The company initially focused on pain management and expanded its portfolio through strategic acquisitions and product development. Over the years, Endo has acquired several companies, including Paladin Labs, Par Pharmaceutical, and Auxilium Pharmaceuticals, to enhance its product offerings and market presence.
Business Segments[edit | edit source]
Endo International operates through several business segments:
Branded Pharmaceuticals[edit | edit source]
This segment includes the development and marketing of branded prescription products. Key therapeutic areas include pain management, urology, and endocrinology.
Sterile Injectables[edit | edit source]
Endo's sterile injectables segment focuses on the production and distribution of injectable products, including generic and branded formulations.
Generic Pharmaceuticals[edit | edit source]
The generic pharmaceuticals segment involves the development, manufacturing, and marketing of generic drugs. This segment was significantly expanded through the acquisition of Par Pharmaceutical.
Products[edit | edit source]
Endo International offers a wide range of products across various therapeutic areas. Some of the notable products include:
- [[Opana ER - An extended-release opioid analgesic for pain management.
- [[Xiaflex - A collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture and Peyronie's disease.
- [[Vasostrict - A vasopressin injection used to increase blood pressure in adults with vasodilatory shock.
Controversies[edit | edit source]
Endo International has faced several controversies, particularly related to its opioid products. The company has been involved in litigation concerning the marketing and distribution of opioid medications, which have been linked to the opioid epidemic in the United States.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
